Cargando…

Fetal Gene Reactivation in Pulmonary Arterial Hypertension: GOOD, BAD, or BOTH?

Pulmonary arterial hypertension is a debilitating chronic disorder marked by the progressive obliteration of the pre-capillary arterioles. This imposes a pressure overload on the right ventricle (RV) pushing the latter to undergo structural and mechanical adaptations that inexorably culminate in RV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemay, Sarah-Eve, Awada, Charifa, Shimauchi, Tsukasa, Wu, Wen-Hui, Bonnet, Sébastien, Provencher, Steeve, Boucherat, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231250/ https://www.ncbi.nlm.nih.gov/pubmed/34208388 http://dx.doi.org/10.3390/cells10061473

Ejemplares similares

Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension
por: Grobs, Yann, et al.
Publicado: (2021)

Dual ET(A)/ET(B) blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension
por: Nadeau, Valerie, et al.
Publicado: (2017)

PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
por: Shimauchi, Tsukasa, et al.
Publicado: (2022)

DNA Damage and Pulmonary Hypertension
por: Ranchoux, Benoît, et al.
Publicado: (2016)

The cancer theory of pulmonary arterial hypertension
por: Boucherat, Olivier, et al.
Publicado: (2017)

Reverse Reaction of Nicotinamide Nucleotide Transhydrogenase Promotes ROS Production and Contributes to Right Ventricular Failure
por: Lemay, Sarah-Eve, et al.
Publicado: (2022)

Right Ventricular Dysfunction in Pulmonary Hypertension: Is Resistin a Promising Target?
por: Lemay, Sarah‐Eve, et al.
Publicado: (2023)

Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach
por: Habbout, Karima, et al.
Publicado: (2021)

Reply to Chen et al.: BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
por: Provencher, Steeve, et al.
Publicado: (2020)

Reply to Ning et al.: More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension
por: Provencher, Steeve, et al.
Publicado: (2020)

Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges
por: Lajoie, Annie-Christine, et al.
Publicado: (2017)

HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension
por: Boucherat, Olivier, et al.
Publicado: (2017)

Pim-1: A new biomarker in pulmonary arterial hypertension
por: Renard, Sébastien, et al.
Publicado: (2013)

Leptin, Both Bad and Good Actor in Cancer
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021)

Interpreting risk reduction in clinical trials for pulmonary arterial hypertension
por: Lajoie, Annie C., et al.
Publicado: (2018)

Continuous reduction in cerebral oxygenation during endurance exercise in patients with pulmonary arterial hypertension
por: Malenfant, Simon, et al.
Publicado: (2020)

Reactive oxygen species: The good, the bad, and the enigma
por: Ogrunc, Müge
Publicado: (2014)

COVID-19 and the pulmonary vasculature
por: Provencher, Steeve, et al.
Publicado: (2020)

Signal transduction in the development of pulmonary arterial hypertension
por: Malenfant, Simon, et al.
Publicado: (2013)

Alternatives to the Six-Minute Walk Test in Pulmonary Arterial Hypertension
por: Mainguy, Vincent, et al.
Publicado: (2014)

The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?
por: Gorman, Dora M., et al.
Publicado: (2016)

Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms
por: Malenfant, Simon, et al.
Publicado: (2021)

Reply to Piquereau and Perros and to Pullamsetti and de Jesus Perez
por: Kurakula, Kondababu, et al.
Publicado: (2019)

Heat stress and dehydration in adapting for performance: Good, bad, both, or neither?
por: Akerman, Ashley Paul, et al.
Publicado: (2016)

Compromised Cerebrovascular Regulation and Cerebral Oxygenation in Pulmonary Arterial Hypertension
por: Malenfant, Simon, et al.
Publicado: (2017)

Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis
por: Guay, Charles-Antoine, et al.
Publicado: (2018)

Good and bad fever
por: Cavaillon, Jean-Marc
Publicado: (2012)

Aggression—Good or Bad?
por: Ratcliffe, T. A.
Publicado: (1962)

Good and Bad Teeth
Publicado: (1869)

The Good, the Bad and the Tick
por: Cabezas-Cruz, Alejandro, et al.
Publicado: (2019)

Good and Bad Filters
por: Bissell, Wm. G.
Publicado: (1912)

Eggs Good and Bad
Publicado: (1870)

Good and Bad Medicines
Publicado: (1873)

Revisiting the Role for HIF Stabilizers in Bronchopulmonary Dysplasia
por: Boucherat, Olivier, et al.
Publicado: (2020)

2251: An estrogen receptor α (ERα)-BMPR2-apelin axis mediates 17β-estradiol’s protective effects on right ventricular function in experimental pulmonary hypertension (PH)
por: Lee Frump, Andrea, et al.
Publicado: (2018)

The Good, Bad and not so Bad of Positive Thinking and Recovery
por: Chaturvedi, Santosh K.
Publicado: (2023)

Actin cytoskeleton remodeling at the cancer cell side of the immunological synapse: good, bad, or both?
por: Ockfen, Elena, et al.
Publicado: (2023)

Good Estrogen Bad Estrogen
por: Barrett, JR
Publicado: (2000)

ICU readmission: good or bad?
por: Potter, E, et al.
Publicado: (2011)

Offshoring IT: the good, the bad, and the ugly
por: Blunden, Bill, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_aa83kihnbi0bp068lst5278cu0